MAPT and Alzheimer disease: 2.3. Immunofluorescence Staining Using Different Antigens on NAM Co-Cultures Treated with CSF from AD (Aβ+Tau and Aβ-Tau), Non-AD (Non-AD), and PBS (Control) Subjects